CoreCodeTherapeutically

  • [2] [b]Therapeutically:[/b]
    • [2] Empirically:
      • [2] Anti-platelet agent: ASA
        • Empirically administered given ddx includes ACS and potential benefit outweighs potential harm
        • 162mg PO chewed
        • 325mg PO chewed
        • __
      • [2] IVF
        • 30 cc/kg, 
        • 250cc, 
        • 500cc, 
        • 1 L, 
        • 2 L, 
        • __
      • [2] Analgesia: 
        • acetaminophen,  
        • ibuprofen, 
        • hydrocodone/acetaminophen (pt informed not to drive/drink/take fall precautions/not make significant decisions for remainder of day)
        • morphine, 
        • ketorolac, 
        • hydromorphone
        • __
        • haloperidol (haldol)
          • indication:
            • sx refractory to other analgesia,
            • side effect profile of opioids likely to exacerbate symptoms, 
          • 3mg
            • IV 
            • IM 
          • 5 mg
            • IM 
            • IV 
          • 10mg
            • IM 
        • __
      • [2] Anti-emetics
        • ondansetron (zofran), 
          • IV, 
          • ODT [::- oral dissolving tablet -::]
          • __
        • metoclopramide (reglan), 
          • 5 mg, 
          • 10mg, 
          • PO, 
          • IV, 
          • IM, 
        • lorazepam,
          • indication: 
            • prolonged QTC make risk of other similar medications that would prolong QTC prudent to avoid, 
            • sx refractory to other anti-emetics, 
        • haloperidol (haldol)
          • indication:
            • sx refractory to other anti-emetics, 
            • pain refractory to other analgesia, 
            • suspected to have quality of component of pain that may benefit from analgesic effects, 
            • __
          • 3mg
            • IV 
            • IM 
          • 5 mg
            • IM 
            • IV 
          • 10mg
            • IM 
        • __
      • [2] Anxiolytic
        • lorazepam
          • 0.5 mg
          • 1 mg
          • 2mg 
          • PO
          • IV
          • IM
    • [2] Anti-biotics: 
      • Timing: 
        • [01] administered as promptly as source identified with sufficient likelihood to inform appropriate antibiotics (goal directed)
        • administered when source identified
        • administered within 1 hrs from triage
        • administered within 3 hrs from triage
        • __
      • Regimen:
        • ceftriaxone 1 g IV
        • ceftriaxone 1g IV / azithromycin 500mg IV
        • vancomycin IV / cefepime 1 g IV /  azithromycin 500mg IV
        • ceftriaxone 1g IV / metronidazole 500mg IV
        • Unasyn
        • vancomycin / zosyn
        • cefazoline (ancef) 1 g IV
        • __
    • __

Leave a Comment